This brings back strong memories of standing in line for a terminal outside my dorm cafeteria to check email before getting lunch :)

Netflix is the winner here. WBD is massively overvalued at the price that was being commanded at the end of this deal.

The losers are customers that will see continued consolidation, price hikes, and less quality, new content.

More crap being forced on the world that no one is asking for. This is just another futile attempt to find a use for all this AI BS. Funny thing is though, there just isn't enough workforce optimization (ie layoffs) or increased sales to be had that could possibly offset the insane and unsustainable levels of spending we're seeing on this front. Trying to milk a rock.

Yeah, we don't actually need more feed corn.

Plus why not let the landowners decide what they want to do. Shocking idea, I know.

You know this POS would support an imminent domain takeover of the same farmer's land... to build a datacenter or an oil field.

Because of course the party of "small government" doesn't want land owners to have an autonomy to do what they want with their land.

This is so fu#king stupid. Wind in particular has very little footprint impacting a field's productivity and is generally liked by farmers for the extra, reliable income stream. The wind industry boom in the midwest (building and installing) has really helped out those states (especially Iowa and Nebraska).

But of course, they will bow to anything dear leader (and the petro-conglomerates) demand.

Milorganite has been around for decades and is a human wastewater solids fertilizer product that is very popular for turf fertilization. "Smells like success", after you apply and it gets a little wet, as the lawn community would say.

This seems like an obvious progression to not let this material go to "waste".

I remember loving the IBM Think Pad commercials back then. Mainstream TV ads for laptops. Love it.

My fav was the one where they were at a lunch counter and talking about the laptop tracking for impact if dropped. Guy throws one on the floor: "That's not my laptop..." Other guy... "check please". Gold.

Medicare doesn't pay anything for hearing exams, hearing aid fittings, or hearing aids. Just FYI. So you're wrong in that sense.

But, it is a huge market.

OTC hearing aids have really brought the price down and forced prescription models to become more price competitive.

Still, a proper hearing test and fitting of a few different models to see what you like best is worth the cash if you have it. Plus follow up appointments to get everything dialed in.

But, this could prove a stepping stone for people curious if a proper hearing aid would benefit them.

This IS the Hellscape of our future.

It's like you're a Simpson's episode.

Bloatware creep never ceases.

Here's the one thing that is unabashedly basic and straightforward... for *decades*. NOPE, not allowed.

Ok, Ok... probably fine ;) But I'm an old man Genx-er and want to rant.

I don't get the "Air" moniker these days. The lineup is SO fragmented.

I'd love to see them drop "Air" and just have the MacBook (13.6" and 15.x") and the MacBook Pro (14" and 16").

Then move on and clean up the mess that is the iPad lineup.

In the life/biological sciences at a major US research university, our graduate students are making between $27-$32k (this depends on their particular program). That also receive full tuition coverage and health insurance. $18.7k is crazy low. We could not retail or recruit any students with stipends that low.

Not to mention utility customers as far north as Minnesota are being forced to pay for the irresponsibility of Texas based natural gas companies (Centerpoint Energy) through increased utility bills (and we are being charged interest on it at nearly 9% to boot!).

From the perspective of a PhD trained cancer researcher, working on drug discovery/development in academia:

The cost might seem high. Some people think the cost is really going to make these types of cellular based therapy difficult to push into wide spread use. I'm more hopeful that new technology will drive down the cost in coming years. The techniques used to make these cells are years old at this point. That's just how long it takes to get things approved and trials conducted.

But remember the following:

1. This isn't (nor would you want it to be) front line therapy. It's for relapsed or non-responsive b-cell ALL. The side effect profile is risky, this therapy can kill a person, and there are life long implications to receiving it.

2. This is the first approved cellular therapy for wide spread use. It cost a massive amount of money to do the research and push this through the approval process. Billion of dollars for a product not very many people will get.

3. It isn't something that can be made and stored on a shelf. They take your cells out, process them, use a retrovirus to insert a new chimeric antigen receptor into them to target B-cells, and then reinfuse that into the patient. It's personalized medicine to the extreme.

3. The facilities to do what's listed in 2 are insanely costly to build and run, as their are extreme biosafety concerns when altering cells and putting them back into a person. The use of retroviruses makes the biosafety converses higher. Newer technologies will improve this aspect, but haven't been vetted and approved yet.

4. There would be many people involved in making these modified T cells, all of whom likely have masters degrees or PhDs. I'm not talking about the research side to develop them... but production. It's that involved.

5. This is in line with or in most cases cheaper than bone marrow transplants, which are fairly common for other cancers.

6. Novartis will only bill for the product if a patient shows a response within 30 days.

7. These patients have essentially few other options and would likely die without this therapy.

What could possibly go wrong? :)